Michael C. Milone
Hospital of the University of Pennsylvania · 321 works · 23,975 citations · h-index 56
Top works
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- CAR T cell immunotherapy for human cancer
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules
- Clinical use of lentiviral vectors
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
- The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses.
- Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
- Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
- The Mannose Receptor Mediates Induction of IFN-α in Peripheral Blood Dendritic Cells by Enveloped RNA and DNA Viruses
- Functional deficiencies in two distinct interferon α-producing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients
- The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma